Fractalkine (CX 3 CL1) to fractalkine receptor (CX 3 CR1) interactions in the brain are involved in the modulation of microglial activation. Our recent findings indicate that there is microglial hyperactivity in the aged brain during an inflammatory challenge. The underlying cause of this amplified microglial response in the aged brain is unknown. Therefore, the purpose of this study was to determine the degree to which age-associated impairments of CX 3 CL1 and CX 3 CR1 in the brain contribute to exaggerated microglial activation after intraperitoneal (i.p.) injection of lipopolysaccharide (LPS). Here we show that CX 3 CL1 protein was reduced in the brain of aged (18-22 mo) BALB/c mice compared to adult (3-6 mo) controls. CX 3 CL1 protein, however, was unaltered by LPS injection. Next, CX 3 CR1 levels were determined in microglia (CD11b + /CD45 low ) isolated by Percoll density gradient separation at 4 and 24 h after LPS injection. Flow cytometric and mRNA analyses of these microglia showed that LPS injection caused a marked decrease of CX 3 CR1 and a simultaneous increase of IL-1b at 4 h after LPS injection. While surface expression of CX 3 CR1 was enhanced on microglia of adult mice by 24 h, it was still significantly downregulated on a subset of microglia from aged mice. This protracted reduction of CX 3 CR1 corresponded with a delayed recovery from sickness behavior, prolonged IL-1b induction, and decreased TGFß expression in the aged brain. In the last set of studies BV2 microglia were used to determine effect of TGFß on CX 3 CR1. These results showed that TGFb enhanced CX 3 CR1 expression and attenuated the LPS-induced increase in IL1b expression.
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Introduction
Microglia are part of the innate immune system in the CNS and play an important role in interpreting and propagating inflammatory signals in response to activation of the peripheral immune system (Davalos et al., 2005; Nguyen et al., 2002; Nimmerjahn et al., 2005) . Several studies using older rodents, non-human primates, and humans indicate that the profiles of microglia and astrocytes become more inflammatory with age. For example, markers of glial reactivity or priming, such as major histocompatibility complex (MHC) class II, are increased in the brain during normal aging (Godbout and Johnson, 2006; Perry et al., 2003; Wynne et al., 2009) . Recent studies in older rodents indicate that a potential consequence of a reactive glial profile is an exaggerated neuroinflammatory cytokine response to either central (Abraham et al., 2008; Huang et al., 2008) or peripheral (Chen et al., 2008; Godbout et al., 2005b; Henry et al., 2008 Henry et al., , 2009 (Abraham et al., 2008; Godbout et al., 2005a; Huang et al., 2008) , and protracted depressive-like behavior (Godbout et al., 2008) . Collectively, these data point to an impaired ability to regulate microglia in the aged brain.
Recent data has begun to establish fractalkine (CX 3 CL1) to fractalkine receptor (CX 3 CR1) interactions as an important mechanism of microglial regulation. CX 3 CL1 is a member of the CX 3 C family of chemokines (Harrison et al., 1998; Nishiyori et al., 1998; Pan et al., 1997) and is one of the few chemokines that is highly expressed in the brain (Pan et al., 1997; Sunnemark et al., 2005; Tarozzo et al., 2003) . CX 3 CL1 exists both as a $95 kDa membrane-bound ligand and a $65 kDa soluble glycoprotein (Harrison et al., 1998) . Complementary expression of CX 3 CL1 on neurons and CX 3 CR1 on microglia (Hughes et al., 2002; Maciejewski-Lenoir et al., 1999; Nishiyori et al., 1998; Pan et al., 1997) has led to the hypothesis of a unique communication system where neurons constitutively express and release CX 3 CL1 to modulate activation of microglia (Cardona et al., 2006) .
